Rapid Micro Biosystems (RPID) Operating Margin (2020 - 2026)
Rapid Micro Biosystems recorded quarterly Operating Margin of 173.11% in Q1 2026, down 59.94% quarter-over-quarter from 108.23% in Q4 2025, and down 1126.0% year-over-year from 16.87% in Q1 2025.
Rapid Micro Biosystems' Operating Margin history runs 7 years deep, the most recent figure standing at 173.11% for Q1 2026.
- In Q1 2026, Operating Margin fell 1126.0% year-over-year to 173.11%; the TTM figure through Mar 2026 stood at 144.2% (up 1537.0% YoY), while the FY2025 annual figure was 141.1%, up 3686.0% from the prior year.
- Operating Margin came in at 173.11% for Q1 2026 at Rapid Micro Biosystems, down from 108.23% in the prior quarter.
- In the past five years, Operating Margin ranged from a high of 108.23% in Q4 2025 to a low of 394.6% in Q4 2022.
- A 5-year average of 234.99% and a median of 202.15% in 2024 frame the typical range for Operating Margin.
- Across the five-year window, Operating Margin sank 18742 bps in 2022 and soared 20227 bps in 2023, its largest moves.
- Rapid Micro Biosystems' Operating Margin stood at 394.6% in 2022, then soared by 51 bps to 192.33% in 2023, then soared by 35 bps to 124.47% in 2024, then increased by 13 bps to 108.23% in 2025, then sank by 60 bps to 173.11% in 2026.
- According to Business Quant data, Operating Margin over the past three periods registered 173.11%, 108.23%, and 145.09% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 12.05% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 15.55% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 16.24% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 21.16% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 28.97% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 6.17% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 21.42% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 10.04% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 19.94% |
| 10 | Rapid Micro Biosystems | 89.50 Mn | 66.56 Mn | 371,000.00 | -173.11% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -173.11% |
| Dec 31, 2025 | -108.23% |
| Sep 30, 2025 | -145.09% |
| Jun 30, 2025 | -167.28% |
| Mar 31, 2025 | -161.85% |
| Dec 31, 2024 | -124.47% |
| Sep 30, 2024 | -158.32% |
| Jun 30, 2024 | -202.15% |
| Mar 31, 2024 | -254.38% |
| Dec 31, 2023 | -192.33% |
| Sep 30, 2023 | -235.13% |
| Jun 30, 2023 | -300.96% |
| Mar 31, 2023 | -295.37% |
| Dec 31, 2022 | -394.60% |
| Sep 30, 2022 | -356.32% |
| Jun 30, 2022 | -364.61% |
| Mar 31, 2022 | -360.55% |
| Dec 31, 2021 | -279.49% |
| Sep 30, 2021 | -175.72% |
| Jun 30, 2021 | -177.19% |
| Mar 31, 2021 | -194.01% |
| Dec 31, 2020 | -185.47% |
| Sep 30, 2020 | -144.41% |
| Jun 30, 2020 | -231.85% |